Multiple Xanthoma Tuberosum in a Case of Familial Homozygous Hypercholesterolemia
DOI:
https://doi.org/10.15605/jafes.038.01.17Keywords:
xanthoma, familial, hypercholesterolemia, LDLAbstract
A 15-year-old, Indian, female child of a second-degree consanguineous marriage, presented with polymorphic yellowish-brown nodular cutaneous lesions over the dorsal aspect of both elbows, knees (Figure 1A) and buttocks (Figure 1B). These were suggestive of xanthoma tuberosum and were first noted at 4 years old. There were no spots over the eyelids, acanthosis, skin tags or tendon xanthomas. Arcus juvenilis was not noted. A bilateral carotid bruit was appreciated.
Downloads
References
Mozas P, Cenarro A, Civeira F, Castillo S, Ros E, Pocovi M. Mutation analysis in 36 unrelated Spanish subjects with familial hypercholesterolemia: Identification of 3 novel mutations in the LDL receptor gene. Hum Mutat. 2000;15(5):483-4. https://pubmed.ncbi.nlm.nih.gov/10790219. https://doi.org/10.1002/(SICI)1098-1004(200005)15:5<483::AID-HUMU19>3.0.CO;2-Q.
Risk of fatal coronary heart disease in familial hypercholesterolemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ. 1991; 303(6807):893-6. https://pubmed.ncbi.nlm.nih.gov/1933004. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1671226. https://doi.org/10.1136/bmj.303.6807.893.
Müller C. Angina pectoris in hereditary xanthomatotic. Arch Intern Med (Chic). 1939;64(4):675–700. https://doi.org/10.1001/archinte.1939.00190040016002.
Kasper DL, Fauci AS, Hauser S, et al. Harrison’s principles of internal medicine, 19th ed., vol. 2. New York: McGraw-Hill; 2015.
Maliachova O, Stabouli S. Familial hypercholesterolemia in children and adolescents: Diagnosis and treatment. Curr Pharm Des. 2018;24(31):3672-7. https://pubmed.ncbi.nlm.nih.gov/30317987. https://doi.org/10.2174/1381612824666181010145807.
Mach F, Baigent C, Catapano A; for The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. European Heart Journal. 2020;41(1); 111 -88. https://doi.org/10.1093/eurheartj/ehz455.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pankaj Singhania, Pritam Biswas, Abhranil Dhar

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.





